JPH0916681A - Medicine discriminating device - Google Patents

Medicine discriminating device

Info

Publication number
JPH0916681A
JPH0916681A JP18214795A JP18214795A JPH0916681A JP H0916681 A JPH0916681 A JP H0916681A JP 18214795 A JP18214795 A JP 18214795A JP 18214795 A JP18214795 A JP 18214795A JP H0916681 A JPH0916681 A JP H0916681A
Authority
JP
Japan
Prior art keywords
drug
medicine
data
computer
brand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP18214795A
Other languages
Japanese (ja)
Inventor
Bunkichi Kato
藤 文 吉 加
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP18214795A priority Critical patent/JPH0916681A/en
Publication of JPH0916681A publication Critical patent/JPH0916681A/en
Pending legal-status Critical Current

Links

Landscapes

  • Image Processing (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

PURPOSE: To automatically discriminate each medicine by preparing a data base for registering the appearance condition of each brand, inquiring a preparing medicine to be inspected by a computer by using its appearance condition as a retrieving item and specifying the brand name of the medicine by the matching of retrieval. CONSTITUTION: One component of propionic acid group antipyretic/analgesics, e.g., is selected from an indication list issued from Japanese Pharmacist Association, the constitutional formula part of the medicine is converted into image data, the other noun part is convered into a free keyword to electronically express the medicine data, and while referring to formulation identification codes described at the end of Japanese pharmaceutical list, electronic identification recording data such as a mark and a symbol in each brand are prepared. Physical measuring data consisting of the weight, maximum diameter, color, capsule size of each medicine brand are electronically stored and these data are identified by a bar code in each product. When a formulation characteristic is used as a retrieving item and inputted to a computer 1 to 4 by manual operation, a completely coincident product name is retrieved from an existing data base, the product name can be specified.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、コンピュータの照会検
索機能を利用した薬剤鑑別自動化装置にかかる。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an automated drug discrimination apparatus utilizing the inquiry and retrieval function of a computer.

【0002】[0002]

【従来技術】コンピュータ、電子化機器、ソフトの発展
は最近めざましいものがあり、米国ではすでに情報ハイ
ウェーが構築され、通信、ケーブルテレビが一般家庭に
普及すると共に、マルチメデア化された産業構造の変化
が着実に進みつつある。我が国でも小規模ではあるが小
売店の在庫管理業務、特許手続等の分野では電子化が進
みつつあるものの、規格が不統一であり、厳しい規制や
通信料金が高価である背景もありいっこうに進展しない
のが実情である。特に医療産業分野にあっては試験的に
電子処方箋や病院総合情報システム等の開発は試みられ
てはいるが、診療保健点数請求の問題等も含み未だ手作
業の域を脱していない[東芝病院情報システム、ARI
S副作用データーベース(小田島)、電子カルテ(日本
保健医療情報システム工業会等)]。
2. Description of the Related Art The development of computers, electronic devices, and software has been remarkable recently. With the construction of information highways in the United States, the spread of communication and cable television in ordinary households, and the change in the industrial structure that has become multi-media. Steadily progressing. Although it is a small scale in Japan, although digitization is in progress in fields such as retail inventory management and patent procedures, progress is made further due to the fact that standards are not uniform, strict regulations and communication charges are expensive. The reality is not to do it. Especially in the medical industry, trial development of electronic prescriptions and comprehensive hospital information systems has been attempted, but due to problems such as the claim for medical health points, the manual work is still in progress [Toshiba Hospital Information system, ARI
S side effect database (Odashima), electronic medical record (Japan Healthcare Information Systems Industry Association, etc.)].

【0003】[0003]

【発明が解決しようとする問題点】最近、訪問診療制度
がわが国でも発足し、訪問員が患者に薬剤の問い合わせ
を受けるケースや、薬袋入り調剤ずみ薬品の中身を検定
する場合、よほど専門家でないかぎり視覚的判別はでき
ず、処方者に確認する必要から判別までに極めて長時間
を要するケースが多い。このため患者の素朴な質問・疑
問に即答できない問題点があった。
[Problems to be solved by the invention] Recently, a visiting medical care system has also been established in Japan, and it is not so expert when a visitor receives a drug inquiry from a patient or when examining the contents of a dispensed drug in a medicine bag. As long as it is not possible to make a visual distinction, it often takes a very long time to make a distinction because it is necessary to confirm it with the prescriber. For this reason, there is a problem that the patient's simple questions cannot be answered immediately.

【0004】我国の医薬品(以下薬剤)は医家向と一般
用に大別される。一般用薬剤は直接、服用者が薬局から
説明を受け購入し、効能書や成分名が添付されているの
で、問題となるケースは少ないが、医家向薬剤は、副作
用未知の新薬が多い反面、効能書を実際服用する患者が
見る機会はなく、専門家の処方を信ずる事が基本とされ
ている。このため、患者不安、医療事故における正確な
投薬把握ができない等の問題点が指摘されている(精神
的効果と言う点で服用者は薬物名を知る権利がないとす
る考え方)。
Pharmaceuticals in Japan (hereinafter referred to as pharmaceuticals) are roughly classified into those for physicians and those for general use. Over-the-counter drugs are directly purchased by the user after receiving explanations from the pharmacy, and the efficacy statement and ingredient names are attached, so there are few problems, but for medical doctors, many new drugs with unknown side effects, Patients who actually take efficacy indications do not have the opportunity to see it, and it is basically believed that they believe in the prescription of a specialist. Therefore, problems such as patient anxiety and inability to accurately grasp medication in medical accidents have been pointed out (thinking that the user does not have the right to know the drug name in terms of mental effects).

【0005】医家向薬剤は、保険負担であるため患者の
実支払い額が少ない利点もあるが(多種多量の薬剤が価
格を度外視し投薬される場合が多い)、患者が複数の診
療機関を平行通院したり、成分・名称不明の精神薬や麻
酔薬を飲み残し、万病薬と考え家族や知人に譲ったりす
る問題点も指摘されている。
[0005] The medicine for medical practitioners has an advantage that the actual payment amount of the patient is small because it is an insurance burden (often, many kinds of medicines are dispensed without paying attention to the price), however, the patient does not operate in parallel with a plurality of medical institutions. It has been pointed out that there are problems in going to the hospital or leaving psychiatric drugs or anesthetics with unknown ingredients and names, and leaving them to families and acquaintances because they think they are all medicines.

【0006】最悪のケースではメーカーや診療機関が間
違えて薬品を処方する場合(抗癌剤の製造ラインと胃腸
薬の製造ラインが同一であったため、抗癌剤原料を胃腸
薬と間違え製造包装してしまったケース等)すら発生し
ており、たとえ許認可メーカー、専門家と言えども人的
ミス防止のため複数チェック機能の充実が叫ばれている
In the worst case, when a manufacturer or a medical institution mistakenly prescribes a drug (since the production line of the anticancer drug and the production line of the gastrointestinal drug are the same, the raw material of the anticancer drug is mistakenly manufactured as the gastrointestinal drug and is packaged. Etc.), even if it is a licensed manufacturer or an expert, the enhancement of multiple check functions is called for to prevent human error.

【0007】{複数の医療機関でかけもち診療を受けた
患者が医薬品の重複投与を受け死亡した例(投薬量の増
量)、飲み合わせ処方により死亡した例(飲合せ中
毒)、ウイルス混在、新薬の副作用報告が行政規制によ
り末端に届くまで時間を要し死亡例や感染数が増加した
例等(ソリブジン・抗癌剤の重複投与事件、かけもち受
診事件、血液製剤によるエイズ感染事件〜よほど被害が
発生しない限り摘発される場合は少ないが被害が発生し
てからでは遅い)}
{Patients who have been practicing medical care at a plurality of medical institutions and died due to repeated administration of medicines (increased dose), patients died due to swallowing prescription (drinking poisoning), virus mixture, new drug It took time for the side effect report to reach the end due to administrative regulations and the number of deaths and the number of infections increased, etc. There are few cases of being caught, but it is slow after the damage occurs)}

【0008】このため、分業制度確立の必要性(投薬
ミスや重複処方を避ける目的で医療と投薬を分離し独立
した別々の機関でダブルチェックする機能)や、デス
カバリー、デスクロージャー制度(診療記録の第三者機
関による一元化保管証拠保全機能、開示義務)、イン
ホームド・コンセンス(精神治療以外は処方箋を受け取
った時点で、患者自身が服用する薬品名を確認でき、希
望すれば処方内容によっては投薬説明が自由に受けられ
る制度)、新薬縦覧制度の導入等、欧米先進諸国並の
末端消費者に優しい制度改革の必要性が叫ばれているも
のの、我国の医薬品は同種同効薬が多種類存在しており
(その数は1万種類にも及ぶと言われ、世界有数の医薬
品多量消費市場)その既得権、複雑・繁雑さもあり、い
っこうに進展しないのが実情である。
[0008] Therefore, it is necessary to establish a division of labor system (function to separate medication and medication for the purpose of avoiding medication mistakes and duplicate prescriptions and double-check at independent independent institutions), discovery, disclosure system (medical record Centralized storage evidence preservation function by a third-party organization, obligation to disclose), Informed Consensus (Except for psychotherapy, when the prescription is received, the name of the drug taken by the patient himself / herself can be confirmed, and if desired, explanation of the medication depending on the prescription content. However, there is a need for institutional reforms that are as easy as the end-of-the-Western countries, such as the introduction of new drug inspection systems. (It is said that the number of them is 10,000, and it is one of the world's leading large-volume consumer markets for pharmaceuticals.) Due to its vested interests, complexity and complexity, it is difficult to make any progress. It is.

【0009】毎年数100種類にもわたる薬品が発売さ
れ、益々その数は増大傾向にある。同一成分の薬であっ
てもメーカーごとに外観、形状は異なっており、専門家
向の『錠剤鑑別辞典(病院薬剤部編)』『日本医薬品集
(医薬情報センター)』とか、患者向の『医者からもら
った薬がわかる本、薬局で売られている薬がわかる本
(講談社)』等の書籍類は販売されているが、検索項目
が視覚的範囲から構成されており(ヒートシールや記号
からの判別)、よほどの専門家であっても鑑別に時間が
かかる欠陥があった。
Several hundred kinds of chemicals are released every year, and the number of them is increasing more and more. Even if the drugs have the same ingredients, the appearance and shape are different depending on the manufacturer. For example, "Tablet identification dictionary (hospital pharmacy department)""Nippon Pharmaceutical Collection (medical information center)" for specialists Books such as the book that tells me the medicine I got from a doctor and the book that tells me the medicine sold at the pharmacy (Kodansha) are on sale, but the search items consist of visual range (heat seals and symbols There is a defect that it takes time for discrimination even for a proper expert.

【0010】特に、包袋、シールがはぎ取られた錠剤、
カプセル剤あるいは散剤等を組み合わせた調剤品(一回
使用量ごとに包装処方された後等)では、物理化学的性
質についての確認試験でも試験機関に依頼し、数日待た
ない限り判別は不可能な状況である。
In particular, a packet, a tablet whose seal has been peeled off,
For preparations in which capsules or powders are combined (after being packaged for each dose, etc.), it is impossible to make a distinction without asking the testing institute for confirmation tests of physicochemical properties and waiting for a few days. It is a situation.

【0011】[0011]

【問題点を解決するための手段及び作用】[Means and actions for solving the problems]

(発明の概要)本発明はこれら上述の問題点を解決する
ための薬剤識別自動化方法と装置を提案するものであ
る。
(Summary of the Invention) The present invention proposes an automated drug identification method and apparatus for solving the above problems.

【0012】第一方式は従来冊子体を用いて手引きで調
査していた方式から、コンピュータ照会検索方式に単純
に転用するだけのものである。この方式はブランドごと
の外観条件(マーク、コード、番号)を登録したデータ
ベースを予め作成し、これから、調査したい調剤薬から
外観条件を検索項目としてコンピュータ内で照会一致検
索を行い、一致する薬剤から商品名を特定する方式であ
る。この方式は固形剤で刻印されたマーク、コード、番
号等の外観識別項目が明確に記載されている製剤や、顆
粒、散剤であっても包袋部分にブランド名、成分記載が
あるものに限定し使用する事ができる。
[0012] The first method is a method in which a booklet body is used for a manual investigation, but is simply diverted to a computer inquiry retrieval method. This method creates a database in which the appearance conditions (mark, code, number) for each brand are registered in advance, and then a matching search is performed in the computer using the appearance conditions as the search item from the dispensing drug to be investigated, This is a method of specifying the product name. This method is limited to preparations in which appearance identification items such as marks, codes, numbers, etc. that are engraved with solid agents are clearly described, and even in the case of granules and powders, the brand name and ingredients are stated in the packaging part. Can be used.

【0013】第二方式は、外観表示がされていない単一
薬剤についての調査用に使用されるものであり、物質変
性を加えない簡単に測定できる物理的識別項目(重量、
色調、光学、磁気、電導度、音波、光線類例えばX線等
を利用した測定値)に限定して、測定機器検知データを
コンピュータ内に電子的に記録し、この調剤製剤ごとの
個別データを検索照会項目として、予め登録されている
商品ごとのデータとの対比を行い(照会検索実行)、ブ
ランド名を特定する方式である。
The second method is used for investigating a single drug without an external display, and is a physical identification item (weight,
Only the color tone, optics, magnetism, electrical conductivity, sound waves, light rays such as X-rays, etc.) are used to electronically record the detection data of the measuring device in the computer, and the individual data for each preparation This is a method of specifying a brand name by performing comparison with data for each product registered in advance as a search inquiry item (execution of inquiry search).

【0014】第三方式は、混合製剤についての調査用に
使用されるものであり、一般的に頻繁に使用される水
剤、散剤の混合処方から得られる物理的識別項目(体
積、重量、粘度、色調混合、光学、磁気、電導度、音
波、X線等を利用した測定値)を予め登録しておき、検
定したい調剤品の物理的識別項目を比較照会する事によ
り、複数の商品名を予測し、所望により含有量まで検定
する方式である。
The third method is used for investigating mixed preparations, and is generally a physical identification item (volume, weight, viscosity) obtained from a mixed formulation of liquid medicines and powders that are often used. , Color mixing, optics, magnetism, conductivity, sound waves, X-rays, etc.) are registered in advance, and multiple product names can be obtained by comparing and inquiring the physical identification items of the preparations to be tested. This is a method of predicting and verifying the content if desired.

【0015】第四方式としては、第三方式による混合製
剤について、これを錠剤、カプセル剤、丸剤、顆粒剤、
細粉末部分に篩分けした後、第一あるいは第二方式によ
りブランド名を特定する方式である。
As the fourth method, the mixed preparation of the third method is used in the form of tablets, capsules, pills, granules,
After sieving into fine powder parts, the brand name is specified by the first or second method.

【0016】実際の使用にあっては、患者向簡易方式と
しては通常第一方式で、記号、番号等の検索項目により
大部分の薬剤が鑑別できるが、内服用固形剤が調剤混合
されている場合は、錠剤、カプセル剤、顆粒剤、丸剤、
散剤にふるいわけた後、これを第二方式により個別に検
定する方法が好ましい。また、散剤の検索にあっては複
数の散剤が混合されている場合もあり第三方式による検
定が好ましい。
In actual use, the first method is usually the simplest method for patients, and most drugs can be distinguished by the search items such as symbols and numbers. However, solid preparations for internal use are mixed in the preparation. In the case of tablets, capsules, granules, pills,
After sieving into powder, a method of individually assaying the powder by the second method is preferable. Further, in the case of powder search, a plurality of powders may be mixed in some cases, and the third method is preferable.

【0017】なお、第一方式は、薬剤の外観入力装置
(キーボードからの手動入力可)とコンピュターと標準
となる薬剤データベース(CDロム版等)があれば十分
であるが、第二、第三、第四方式にあっては、望ましく
は薬剤の化学的性質も同時に検定照会できるようなデー
タベースを構築する事により、オンライン方式で専門家
や診療機関向けにも十分提供できるものである(製造承
認許可時点における製品特性データ、臨床データ、薬効
薬理データ等の電子化が実施され、データベースとして
蓄積される等のインフラ整備が望まれている)。
The first method is sufficient if it has a drug external appearance input device (manual input from a keyboard is possible), a computer and a standard drug database (CD ROM version, etc.). In the fourth method, it is desirable to construct a database so that the chemical properties of the drug can be assayed and inquired at the same time, so that it can be sufficiently provided to specialists and medical institutions by the online method (manufacturing approval). It is desired to establish infrastructure such as digitization of product characteristic data, clinical data, pharmacological data, etc. at the time of approval, and accumulation as a database).

【0018】薬剤の外観表示特性、計測値特性を読取り
記録する方法としては、測定機器を接合しそのまま形状
等の特性を測定、計量して記録する方法(一次読取り方
法)とミクロバーコード等のコンピュータコード類を用
いて特性情報が記録された状態で電子的に読み取る方法
(二次読取り方法)が考案される。
As a method for reading and recording the appearance display characteristics and measured value characteristics of a drug, a measuring instrument is joined and the characteristics such as the shape are directly measured, weighed and recorded (primary reading method), and a micro bar code and the like. An electronic reading method (secondary reading method) is devised in which characteristic information is recorded using computer codes.

【0019】前者は品質が粗悪な場合、読み取りエラー
が発生しやすい問題点もあるが、より現実的である。後
者にあっては半導体チップ等の記録素子、ミクロバーコ
ード等のコンピュータコード類を箱、ラベル、ヒートシ
ールあるいは製剤そのものに記録(印刷)しておき、製
品を特定すると共に規格品の特性データを照会する方法
である。カプセル、錠剤表面に埋込、刻印、印刷する方
法については服用物に記録する場合は安全性の問題を含
め、材質、記録法等今後の規格化が必要であり、現時点
は試験的領域ではあるが、情報が正確に読み取れる点で
今後の発展が期待される。
The former is more realistic although it has a problem that a read error is likely to occur when the quality is poor. In the latter case, recording elements such as semiconductor chips and computer codes such as micro bar codes are recorded (printed) on a box, label, heat seal or the preparation itself, and the product is specified and the characteristic data of the standard product is recorded. It is a method of inquiring. Regarding the method of embedding, engraving, and printing on the surface of capsules and tablets, it is necessary to standardize the material, recording method, etc. in the future, including safety issues when recording on clothes, and it is currently a test area. However, future development is expected in that the information can be read accurately.

【0020】以下には試作試験例をあげ本発明を更に詳
細に説明する。なお、本発明実施例はデーター量を増加
させ、物理的測定項目を増加させることにより、高度な
照会検索機能を付加する事ができる。従って本発明は実
施例に限定されるものではない。
Hereinafter, the present invention will be described in more detail with reference to prototype test examples. In the embodiment of the present invention, an advanced inquiry search function can be added by increasing the amount of data and the number of physical measurement items. Therefore, the present invention is not limited to the examples.

【0021】[0021]

【実施例】【Example】

試作例 1)薬剤データベースの作成 日本薬剤師会発行の能書集からプロピオン酸系解熱性鎮
痛剤1成分(アルクロフェナック)を選択し、構造式部
分はイメージデータとして、他は名詞部分をフリーキー
ワードとして先発品データを電子化し、さらに日本医薬
品集(日本医薬情報センター)巻末部分の製剤識別コー
ドを参考にブランドごとのマーク、記号等の識別記録デ
ーターを電子化したものを作成した。
Prototype example 1) Creation of drug database We selected one component of propionic acid-based antipyretic analgesic (alclofenac) from the booklet published by the Japanese Society of Pharmacists, the structural formula part as image data, and other noun parts as free keywords. As a result, the original product data was digitized and the identification record data such as marks and symbols for each brand were digitized with reference to the formulation identification code at the end of the Japan Pharmaceutical Sciences Collection (Japan Pharmaceutical Information Center).

【0022】物理的測定データとしては薬剤ブランドご
との製品重量、最大径、色調、カプセル号数に限定して
電子化保存し(電子化データ表1、索引検索項目表2、
イメージ入力表3参照)、各製品ごとに普及性の高いバ
ーコードで識別した。
The physical measurement data is stored electronically by limiting the product weight, maximum diameter, color tone, and number of capsules for each drug brand (electronic data table 1, index search item table 2,
Image input table 3), each product is identified by a highly popular barcode.

【0023】[0023]

【表1】 剤型 錠 250mg 薬価14.00 商品名 アルメトシン錠 アロピジン錠 ノイロフェナック錠 ブレクロン錠 製造 辰己 中外 東洋新薬 イセイ 太陽薬品 商品名 メモピシン錠 ラスカージン錠 製造 マルコ製薬 寿製薬 ゼリア 剤型 カプセル 250mg 薬価14.00 商品名 アテネメック アピロジャスト アルフェナジンカプセル 製造 鶴原 陽進堂 長生堂 ケンユ 商品名 アロピジンカプセル ミアスリンカプセル 製造 中外 大東交易 東和[Table 1] Dosage form tablets 250mg Drug price 14.00 Product name Almethosin tablets Allopidine tablets Neurofenac tablets Brecuron tablets Manufacture Tatsumi Chugai Toyo Shinsei Issei Taiyo Yakuhin Co., Ltd. Athens Mech Apyrojust Alphenadine Capsule Manufacturing Tsuruhara Yoshindo Kenseido Kenyu Product Name Allopidine Capsule Miasulin Capsule Manufacturing Chugai Daito Trading Towa

【0024】[0024]

【表2】商品名、製造販売元、製造販売元マーク・記号
(ヒートシール、刻印、印刷)剤形[カプセル:柔カプ
セル、硬カプセル、色調(ボデー、キャップ)、規格
(重量)、薬効][錠剤:フイルムコート、糖衣、裸
(単層、有核、多層)、色調、規格(重量)、薬効]、
標準商品分類(薬効分類)、薬価、一日使用量、化合物
名、一般名、ケミカルアブストラクト・レジストリー番
号、メルクインデクス番号、能書中から作成された要約
文フリーキーワード、重量、最長径、硬度
[Table 2] Product name, manufacturer / manufacturer, manufacturer / manufacturer mark / symbol (heat seal, engraving, printing) Dosage form [capsule: soft capsule, hard capsule, color tone (body, cap), standard (weight), medicinal effect] [Tablet: film coat, sugar coating, naked (single layer, nucleated, multilayer), color tone, standard (weight), medicinal effect],
Standard product classification (medicinal effect classification), drug price, daily dose, compound name, general name, chemical abstract registry number, Merck index number, summary sentence created from the notation free keyword, weight, longest diameter, hardness

【0025】[0025]

【表3】化学構造式、能書、製品外観写真(ヒートシー
ル、製剤部分)、メーカー提供パンフレット販促資料、
製品新聞記事、副作用資料
[Table 3] Chemical structure formula, booklet, product appearance photograph (heat seal, formulation part), pamphlet promotional material provided by the manufacturer,
Product newspaper articles, side effect materials

【0026】2)検定機器の構成 試作試験のため、測定データについては手動でデータを
コンピュータに入力し検索する方法で行った。
2) Structure of test equipment For the trial production test, the measurement data was manually input into the computer and searched.

【0027】3)結果及び考察 製剤特性を検索項目とし、手動でコンピュータに入力す
る方法で既存のデータベースから完全一致検索する事に
より、製品名を特定する手法であるが、製剤特性検定機
器をコンピュータに接続する事により自動検索が可能と
なる。特にバーコードについては小さいバーコードを予
めカプセル表面、錠剤表面に印刷しておき、これを一度
スクリーン上に拡大した上で機器が読み取る方法あるい
は直接読み取る方法で実施できる。
3) Results and Consideration This is a method for identifying a product name by searching for an exact match from an existing database by manually inputting it into a computer, using a formulation property as a search item. By connecting to, automatic search becomes possible. In particular, a small barcode can be printed by printing a small barcode on the surface of the capsule or tablet in advance, enlarging it once on the screen and then reading it by the device or by reading it directly.

【0028】[0028]

【発明の効果】最新製品概要、臨床、副作用データ、製
品特性データを有線あるいは電波受信する方法により膨
大な製品データを保有する必要もなく薬剤を検定する専
門家向け装置手法と、CDロム1枚程度の情報量からな
る製品データを家庭内で操作し薬剤を簡単に調査判別す
る装置手法を提供する。服薬物の趣味的調査から、さら
には診療補助者並びに専門家による薬剤鑑定まで応用範
囲は広い。
[Effects of the Invention] An apparatus method for professionals for assaying drugs without the need to hold huge product data by a method of receiving the latest product outline, clinical data, side effect data, and product characteristic data by wire or radio waves, and one CD ROM (EN) Provided is an apparatus method for easily investigating and discriminating a drug by operating product data having a certain amount of information at home. It has a wide range of applications, from hobby surveys of medications to drug appraisals by medical assistants and experts.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明による薬剤検定ステップ図を示すFIG. 1 shows a drug assay step diagram according to the present invention.

【図2】本発明による製品特性読み取り装置全形図を示
す(バーコード読取装置部分〜薬剤、薬袋に印刷された
バーコードを読取りコンピュータに入力するマウス状周
辺機器)
FIG. 2 shows a complete view of a product characteristic reading device according to the present invention (bar code reading device portion-mouse-like peripheral device for reading a bar code printed on a medicine or medicine bag and inputting it to a computer).

【図3】本発明の製品特性(固形剤形状)読み取り装置
部分一例図を示す(錠剤、カプセル剤を所定の受け口に
入れ、移動式メイジャーによりサイズ、硬度を読取りコ
ンピュータに入力するマウス状周辺機器)
FIG. 3 shows an example of a device characteristic (solid dosage form) reading device portion of the present invention (a mouse-like peripheral device in which a tablet and a capsule are put in a predetermined receiving port, and the size and hardness are read by a movable major to a computer. )

【図4】本発明の製品特性(液剤)読み取り装置部分一
例図を示す(散剤、液剤、軟膏剤等)をあらかじめカプ
セル状器具に入れ、同装置の受け口に入れ震動を与えた
後、光学的に特性を読取り、コンピュータに入力するマ
ウス状周辺機器)
FIG. 4 shows an example of a device characteristic (liquid agent) reading device part of the present invention (powder, liquid agent, ointment, etc.) is put in a capsule-like device in advance, and is put into the receiving port of the device to give a vibration, and then is optically Mouse-like peripheral device that reads characteristics and inputs them to a computer)

【図5】簡易型検定装置全形図を示す(図2〜4記載の
製剤特性読取装置とコンピュータ、キーボード、スクリ
ーンを合体させた簡易型機器例)
FIG. 5 shows a complete view of a simplified assay device (an example of a simplified device in which the formulation characteristic reading device described in FIGS. 2 to 4 and a computer, a keyboard, and a screen are combined)

【図6】本発明の薬剤調査装置基本ブロック図を示す。FIG. 6 shows a basic block diagram of the drug investigation device of the present invention.

【符号の説明】[Explanation of symbols]

1〜中央演算装置、2〜RAM、3〜ROM、4〜イン
ターフェース 5〜マウス、6〜ディスプレー・キーボード、7〜ディ
スク、 8〜製剤検定機器、9〜口径調節式カプセル剤受入れ口
(測定センサー) 10〜口径調節式錠剤受入れ口(サイズ、硬度測定セン
サー) 11〜光学測定センサー、12〜液剤挿入容器受入れ口 13〜通信電気コード、14〜液剤挿入容器、15〜操
作キーボード 16〜液晶表示スクリーン 17〜検定製剤取出しボタン
1-Central Processing Unit, 2-RAM, 3-ROM, 4-Interface 5-Mouse, 6-Display Keyboard, 7-Disc, 8-Preparation Test Equipment, 9-Adjustable Capsule Receiving Port (Measurement Sensor) 10-caliber type tablet receiving port (size and hardness measuring sensor) 11-optical measuring sensor, 12-liquid agent insertion container receiving port 13-communication electric cord, 14-liquid agent inserting container 15, operation keyboard 16-liquid crystal display screen 17 ~ Test product extract button

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】1)薬剤の色調、大きさ、形、記号、マー
ク、コード等の外観表示特性、硬度、重量、比重あるい
は磁気・電導度・音波・光線類例えば可視・赤外・紫外
・X線・透過線・レザー光による計測値特性を電子光学
的に読取り表示画面上に表示・記録する手段と、 2)表示・記録した外観表示特性あるいは計測値特性を
表示画面上で選択し手動あるいは自動入力する手段と、 3)前記入力手段の操作によって指定された計測値特性
を照会検索項目となし、あらかじめ登録されている薬剤
情報データベースの中より検索し、完全一致あるいは近
似する品名(商品名、化合物名等)をスクリーン上に確
率順に表示する手段と、 4)確率順に表示された品名を表示画面上で選択し手動
あるいは自動入力する手段と、 5)該当医薬品の能書(効能、効果、使用上の注意等)
並びに投薬上必要とする学術情報をスクリーン上に表示
する手段を具備し、 上記手段をセンサー、プログラム内臓コンピュータ、薬
剤データベースを用い、スクリーン上で制御操作する事
を特徴とした薬剤鑑別装置
Claims 1) Appearance display characteristics such as color tone, size, shape, symbol, mark, code, etc., hardness, weight, specific gravity or magnetism / conductivity / sound wave / light ray such as visible / infrared / ultraviolet. A means for electronically reading and recording the measured value characteristics by X-rays, transmitted rays, and laser light on the display screen, and 2) manually selecting the displayed and recorded appearance display characteristics or measured value characteristics on the display screen. Alternatively, means for automatically inputting, and 3) a measurement value characteristic designated by the operation of the input means does not serve as an inquiry search item, and is searched from a pre-registered drug information database to completely match or approximate the product name (product Name, compound name, etc.) on the screen in order of probability, 4) means to select the product name displayed in order of probability on the display screen and enter it manually or automatically, 5) a statement of the applicable drug (Indications, effects, precautions for use, etc.)
Also, a drug discrimination device comprising means for displaying academic information required for medication on a screen, and controlling the above means by using a sensor, a computer with a built-in program, and a drug database on the screen.
【請求項2】製剤特性検定センサーとプログラム内臓コ
ンピュータが接合状態にあり、製剤特性検定センサー
が固形剤(錠・丸剤、カプセル剤、散・顆粒剤)、液剤
(液・乳濁・軟膏剤)あるいは薬袋外部からの内容物セ
ンサー機能を有し、コンピュータが照会検索機能ある
いは端末としてホストコンピュータへの接続機能を有
し、医薬品の能書(効能、効果、使用上の注意等)並
びに投薬上必要とする学術情報も同時照会検索できるよ
うに構成されている事を特徴とした薬剤鑑別装置
2. The formulation characteristic sensor and the computer with built-in program are in a joined state, and the formulation characteristic sensor is a solid agent (tablet / pill, capsule, powder / granule), liquid agent (liquid / emulsion / ointment). ) Or the content sensor function from the outside of the medicine bag, the computer has the inquiry and search function or the function of connecting to the host computer as a terminal, and the function statement (effects, effects, precautions for use, etc.) of the drug and medication. A drug identification device characterized by being configured so that required academic information can be searched and retrieved at the same time.
JP18214795A 1995-06-26 1995-06-26 Medicine discriminating device Pending JPH0916681A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18214795A JPH0916681A (en) 1995-06-26 1995-06-26 Medicine discriminating device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18214795A JPH0916681A (en) 1995-06-26 1995-06-26 Medicine discriminating device

Publications (1)

Publication Number Publication Date
JPH0916681A true JPH0916681A (en) 1997-01-17

Family

ID=16113188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18214795A Pending JPH0916681A (en) 1995-06-26 1995-06-26 Medicine discriminating device

Country Status (1)

Country Link
JP (1) JPH0916681A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003515552A (en) * 1999-12-03 2003-05-07 サイメディカ リミテッド Pharmaceutical product that can be taken by mouth and method for producing the same
US7218395B2 (en) 2003-04-16 2007-05-15 Optopo Inc. Rapid pharmaceutical identification and verification system
WO2008038775A1 (en) * 2006-09-29 2008-04-03 Yuyama Mfg. Co., Ltd. Medicine management guidance support system
CN104134283A (en) * 2014-08-18 2014-11-05 唐山高达科技有限公司 Automatic unattended medicine vending machine
CN105974149A (en) * 2016-06-29 2016-09-28 胡海潮 Automated drug component content detector for medicine production
KR20160138079A (en) 2014-03-31 2016-12-02 가부시키가이샤 유야마 세이사쿠쇼 Medicine photographing device
WO2018173649A1 (en) 2017-03-23 2018-09-27 富士フイルム株式会社 Drug recognizing device, drug recognizing method, and drug recognizing program
KR20180137492A (en) 2016-04-19 2018-12-27 가부시키가이샤 유야마 세이사쿠쇼 An image processing program, and an image processing apparatus

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003515552A (en) * 1999-12-03 2003-05-07 サイメディカ リミテッド Pharmaceutical product that can be taken by mouth and method for producing the same
US7218395B2 (en) 2003-04-16 2007-05-15 Optopo Inc. Rapid pharmaceutical identification and verification system
WO2008038775A1 (en) * 2006-09-29 2008-04-03 Yuyama Mfg. Co., Ltd. Medicine management guidance support system
JPWO2008038775A1 (en) * 2006-09-29 2010-01-28 株式会社湯山製作所 Drug management guidance support system
JP2013137775A (en) * 2006-09-29 2013-07-11 Yuyama Manufacturing Co Ltd Medicine management guidance support system
US10969218B2 (en) 2014-03-31 2021-04-06 Yuyama Mfg. Co., Ltd. Medicine photographing device
KR20160138079A (en) 2014-03-31 2016-12-02 가부시키가이샤 유야마 세이사쿠쇼 Medicine photographing device
CN104134283A (en) * 2014-08-18 2014-11-05 唐山高达科技有限公司 Automatic unattended medicine vending machine
KR20180137492A (en) 2016-04-19 2018-12-27 가부시키가이샤 유야마 세이사쿠쇼 An image processing program, and an image processing apparatus
KR20210158394A (en) 2016-04-19 2021-12-30 가부시키가이샤 유야마 세이사쿠쇼 Image processing program and image processing device
CN105974149A (en) * 2016-06-29 2016-09-28 胡海潮 Automated drug component content detector for medicine production
WO2018173649A1 (en) 2017-03-23 2018-09-27 富士フイルム株式会社 Drug recognizing device, drug recognizing method, and drug recognizing program
US11574141B2 (en) 2017-03-23 2023-02-07 Fujifilm Toyama Chemical Co., Ltd. Drug recognizing apparatus, drug recognizing method, and drug recognizing program

Similar Documents

Publication Publication Date Title
CA2490189C (en) Method, routines and system for identification of imprints on dosage forms
Ting et al. A drug identification model developed using deep learning technologies: experience of a medical center in Taiwan
Einarson Drug-related hospital admissions
JP7256232B2 (en) Medicine management system and medicine management method
Al-Aqeel Evaluation of medication package inserts in Saudi Arabia
Riaz et al. Medication errors and strategies for their prevention.
WO2002025568A2 (en) Pill identification and prescription management device, system and method
Houglum et al. Principles of pharmacology for athletic trainers
JP4539962B2 (en) Dispensing support system
Takase et al. Evaluating the safety and efficiency of robotic dispensing systems
JPH0916681A (en) Medicine discriminating device
Siden et al. Disintegration of chemotherapy tablets for oral administration in patients with swallowing difficulties
TWM572232U (en) Drug access device
Caillet et al. Role of medicines of unknown identity in adverse drug reaction-related hospitalizations in developing countries: evidence from a cross-sectional study in a teaching hospital in the Lao People’s Democratic Republic
Wade Prescribing of chloramphenicol and aplastic anaemia.
Shonna Yin Health literacy and child health outcomes: parental health literacy and medication errors
JPH08131405A (en) Method and apparatus for standardizing health control technique
Nomura et al. Surface contamination of the outer and blister packages of oral anticancer drugs: A multicenter study
Smith The Prescription'
KR102038673B1 (en) Medication container with function of counseling for taking medicine and counseling system for taking medicine using thereof
Raschke et al. Evaluation of electronic databases used to identify solid oral dosage forms
Jackevicius et al. Accuracy and usability of medication identifiers for solid oral medications
JP2004195033A (en) Support system and method for preventing error in preparation of medicine
Devine et al. Preparing for ambulatory computerized prescriber order entry by evaluating preimplementation medication errors
Houglum et al. Introduction to Pharmacology